Evaluating Models of Open Biopharmaceutical Innovation
- Dr. Minna Allarakhia
- Aug 18, 2020
- 1 min read
The Novartis Institutes for Biomedical Research, Pfizer’s Centers for Therapeutic Innovation, GSK's Centres for Excellence in External Discovery (Working Papers)

Comments